Q32 Bio (QTTB) Cash from Financing Activities (2017 - 2025)
Historic Cash from Financing Activities for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$1.6 million.
- Q32 Bio's Cash from Financing Activities fell 25677.03% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.8 million, marking a year-over-year decrease of 10608.13%. This contributed to the annual value of $95.1 million for FY2024, which is 2333300.49% up from last year.
- Latest data reveals that Q32 Bio reported Cash from Financing Activities of -$1.6 million as of Q3 2025, which was down 25677.03% from $317000.0 recorded in Q4 2024.
- Over the past 5 years, Q32 Bio's Cash from Financing Activities peaked at $99.3 million during Q1 2024, and registered a low of -$5.5 million during Q2 2024.
- Its 5-year average for Cash from Financing Activities is $9.2 million, with a median of $212000.0 in 2022.
- The largest annual percentage gain for Q32 Bio's Cash from Financing Activities in the last 5 years was 66220666.67% (2024), contrasted with its biggest fall of 3691333.33% (2024).
- Quarter analysis of 5 years shows Q32 Bio's Cash from Financing Activities stood at $1000.0 in 2021, then skyrocketed by 3100.0% to $32000.0 in 2022, then soared by 137.5% to $76000.0 in 2023, then skyrocketed by 317.11% to $317000.0 in 2024, then tumbled by 593.06% to -$1.6 million in 2025.
- Its last three reported values are -$1.6 million in Q3 2025, $317000.0 for Q4 2024, and $997000.0 during Q3 2024.